Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-04

Clinical Trial Update: Real-world Effects of Using Intermittently Scanned Continuous Glucose Monitoring and Pharmacist-led Coaching on the Management of Type 2 Diabetes Among Adults Not Using Insulin (REAL isCGM T2D)

View source ↗

Summary

A clinical trial entry for REAL isCGM T2D evaluating real-world effects of intermittently scanned continuous glucose monitoring combined with pharmacist-led coa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: LMC Diabetes & Endocrinology Ltd. | Conditions: Type 2 Diabetes | Status: RECRUITING